Trial Profile
Phase I trial of FRM-0334 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2015
Price :
$35
*
At a glance
- Drugs FRM 0334 (Primary)
- Indications Alzheimer's disease; Dementia; Neurodegenerative disorders
- Focus Adverse reactions
- 10 Feb 2015 Results were published in a FORUM Pharmaceuticals media release.
- 15 Dec 2009 New trial record.